Centre for Radiation Protection Research, Department of Molecular Biosciences, Wenner-Gren Institute, Stockholm University, SE 10691 Stockholm, Sweden.
Mutat Res. 2013 Aug 30;756(1-2):152-7. doi: 10.1016/j.mrgentox.2013.04.014. Epub 2013 May 4.
The aim of the study was to compare the radiation-induced oxidative stress response in blood samples from breast cancer patients that developed severe acute skin reactions during the radiotherapy, with the response in blood samples from patients with no side effects. Peripheral blood was collected from 12 breast cancer patients showing no early skin reactions after radiotherapy (RTOG grade 0) and from 14 breast cancer patients who developed acute severe skin reactions (RTOG grade 3-4). Whole blood was irradiated with 0, 5 and 2000mGy γ-radiation and serum was isolated. The biomarker for oxidative stress, 8-oxo-dG, was analyzed in the serum by a modified ELISA. While a significant radiation-induced increase of serum 8-oxo-dG levels was observed in serum of the RTOG 0 patients, no increase was seen in serum of the RTOG 3-4 patients. The radiation induced increase in serum 8-oxo-dG levels after 5mGy did not differ significantly from the increase observed for 2000mGy in the RTOG 3-4 cohort, thus no dose response relation was observed. A receiver operating characteristic (ROC) value of 0.97 was obtained from the radiation-induced increase in 8-oxo-dG indicating that the assay could be used to identify patients with severe acute adverse reactions to radiotherapy. The results show that samples of whole blood from patients, classified as highly radiosensitive (RTOG 3-4) based on their skin reactions to radiotherapy, differ significantly in their oxidative stress response to ionizing radiation compared to samples of whole blood from patients with no skin reactions (RTOG 0). Extracellular 8-oxo-dG is primarily a biomarker of nucleotide damage and the results indicate that the patients with severe acute skin reactions differ in their cellular response to ionizing radiation at the level of induction of oxidative stress or at the level of repair or both.
本研究旨在比较在放射治疗过程中发生严重急性皮肤反应的乳腺癌患者血液样本中的辐射诱导氧化应激反应与无副作用患者血液样本中的反应。采集 12 例放射治疗后未出现早期皮肤反应(RTOG 0 级)的乳腺癌患者和 14 例发生急性严重皮肤反应(RTOG 3-4 级)的乳腺癌患者的外周血。全血用 0、5 和 2000mGyγ-射线照射,分离血清。采用改良 ELISA 法分析血清中氧化应激标志物 8-oxo-dG。虽然 RTOG 0 患者血清中 8-oxo-dG 水平明显升高,但 RTOG 3-4 患者血清中未见升高。RTOG 3-4 队列中 5mGy 后血清 8-oxo-dG 水平的辐射诱导增加与 2000mGy 观察到的增加无显著差异,因此未观察到剂量反应关系。8-oxo-dG 辐射诱导增加的受试者工作特征(ROC)值为 0.97,表明该测定法可用于识别对放射治疗有严重急性不良反应的患者。结果表明,根据皮肤对放射治疗的反应分类为高度敏感(RTOG 3-4)的患者的全血样本与无皮肤反应(RTOG 0)的患者的全血样本相比,其对电离辐射的氧化应激反应存在显著差异。细胞外 8-oxo-dG 主要是核苷酸损伤的生物标志物,结果表明,严重急性皮肤反应患者在诱导氧化应激或修复水平或两者均存在细胞对电离辐射的反应存在差异。